Description
A mutual prodrug form of ATRA and BA; inhibits the growth of MDA-MB-231 breast and PC3 prostate cancer cells (GI50s = 0.01 and 1.02 µM, respectively); has 15-fold greater antiproliferative activity in PC3 cells compared to an equimolar concentration of ATRA and BA
Formal name: retinoic acid, 4-[(1-oxobutoxy)methyl]phenyl ester
Synonyms:
Molecular weight: 476.7
CAS: 1037543-26-2
Purity: ≥95%
Formulation: A solid